XTS demonstrated significant regulatory effects on this pathological phenomenon, suggesting it can enhance Akkermansia abundance in APP/PS1 mice, exert anti-AD effects through the MGBA, and significantly regulate aberrant carbohydrate metabolism. This evidence concerns the gene APP and Alzheimer disease.